See more : Good Life China Corporation (GLCC) Income Statement Analysis – Financial Results
Complete financial analysis of Initiator Pharma A/S (INIT.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Initiator Pharma A/S, a leading company in the Biotechnology industry within the Healthcare sector.
- Jiangsu Huachang Chemical Co., Ltd. (002274.SZ) Income Statement Analysis – Financial Results
- The Toronto-Dominion Bank (TD-PFI.TO) Income Statement Analysis – Financial Results
- Rush Factory Oyj (RUSH.HE) Income Statement Analysis – Financial Results
- Elron Ventures Ltd (ELRNF) Income Statement Analysis – Financial Results
- Hudson Global, Inc. (HSON) Income Statement Analysis – Financial Results
Initiator Pharma A/S (INIT.ST)
About Initiator Pharma A/S
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 23.41K | 38.43K | 21.63K | 9.30K | 8.37K | 11.44K | 8.18K | 1.05K |
| Gross Profit | -23.41K | -38.43K | -21.63K | -9.30K | -8.37K | -11.44K | -8.18K | -1.05K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 15.30K | 26.34K | 11.81K | 5.19K | 6.26K | 8.67K | 6.09K | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.62K | 3.32K | 1.44K | 1.21K | 886.00 | 1.09K | 1.30K | 262.50 |
| Other Expenses | -15.30K | 3.32M | 1.45M | 1.23M | 973.00K | 1.17M | 1.38M | 187.00K |
| Operating Expenses | 3.62K | 3.32M | 1.45M | 1.23M | 973.00K | 1.17M | 1.38M | 187.00K |
| Cost & Expenses | 27.03K | 3.32M | 1.45M | 1.23M | 973.00K | 1.17M | 1.38M | 187.00K |
| Interest Income | 677.00 | 2.39K | 1.17K | 291.00K | 636.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 2.39M | 1.17M | 0.00 | 636.00K | 93.00K | 801.00K | 5.00K |
| Depreciation & Amortization | 1.00 | 11.00 | 11.00K | 26.00K | 87.00 | 88.00 | 84.00 | 18.00 |
| EBITDA | -27.03K | -41.73K | -23.06M | -10.51K | -9.25K | -12.52K | -9.48K | -1.31K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -27.03K | -41.74M | -23.07M | -10.53M | -9.34M | -12.61M | -9.56M | -887.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -677.00 | -2.39K | -1.17K | 291.00 | -636.00 | -94.00 | -801.00 | -7.50 |
| Income Before Tax | -27.71K | -44.13M | -24.24M | -10.24M | -9.98M | -12.70M | -10.36M | -892.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 4.83K | -5.68M | -3.18M | -1.54M | -1.69M | -2.41M | -1.78M | 11.98K |
| Net Income | -22.87K | -38.46M | -21.06M | -8.70M | -8.29M | -10.30M | -8.58M | -892.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.72 | -0.53 | -0.30 | -0.32 | -0.40 | -0.97 | -0.08 |
| EPS Diluted | 0.00 | -0.72 | -0.53 | -0.30 | -0.32 | -0.40 | -0.97 | -0.08 |
| Weighted Avg Shares Out | 52.42M | 53.23M | 39.69M | 28.99M | 26.12M | 25.89M | 8.86M | 11.23M |
| Weighted Avg Shares Out (Dil) | 52.42M | 53.23M | 39.69M | 28.99M | 26.20M | 25.89M | 8.86M | 11.23M |
Source: https://incomestatements.info
Category: Stock Reports